Economic evaluation of neonatal screening for congenital dislocation of the hip.
A study was undertaken to determine the cost benefit of neonatal screening for dislocatable and subluxable hips. As a follow-up to retrospective and prospective studies that established the safety and efficacy of early treatment to the newborn, this study discusses the direct and significant economic benefit of a neonatal hip screening program to the participating institutions. British Columbia's Grace and Children's Hospitals experienced an economic benefit of $15,143.71 (Canadian) per 1,000 infants screened.
Tredwell
S J
SJ
Department of Orthopaedic Surgery, B.C. Children's Hospital, Vancouver, Canada.
D002170:Canada; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006618:Hip Dislocation, Congenital / Q000175:diagnosis* / Q000191:economics / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000191:economics*; D011446:Prospective Studies; D012189:Retrospective Studies